Skip to main content

UroGen Pharma Ltd 10-Q for FY2022 Q1

UroGen Pharma Ltd. (URGN)

10-Q 2022-05-10 For: 2022-03-31
View Original
Added on April 07, 2026

About this 10-Q

UroGen Pharma Ltd filed this 10-Q on May 10, 2022, covering the quarter ended March 31, 2022 (FY2022 Q1).

Headline figures

Quarter ended March 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$13.56M
up 81.2% from $7.49M a year earlier
Net loss
$28.39M
compared with a net loss of $25.94M a year earlier